ISPERSE

What this means for you

This application is over — abandoned 08 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88766777

Mark type

Design + words

Filed

21 Jan 2020

Published for opposition

13 Oct 2020

Abandoned

08 Jan 2024

Attorney of record

David A. Bell

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals used for the treatment and prevention of diseases, disorders and conditions of the pulmonary system, and for the treatment and prevention of exacerbations of these diseases, disorders and conditions; pharmaceuticals used for the treatment and prevention of infections; pharmaceuticals used for the treatment and prevention of headaches and neurological conditions; drug delivery agents comprising formulations that facilitate delivery of a wide range of pharmaceuticals to the pulmonary system; drug delivery agents comprising formulations that facilitate systemic delivery of a wide range of pharmaceuticals by way of the pulmonary system

Owner

• PULMATRIX OPERATING COMPANY, INC., Lexington, MA, US
• PULMATRIX OPERATING COMPANY, INC., Lexington, MA, US

Prosecution history

• 08 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 08 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
• 18 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 17 Mar 2023 — SOU EXTENSION 5 GRANTED
• 07 Mar 2023 — SOU EXTENSION 5 FILED
• 17 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 07 Mar 2023 — SOU TEAS EXTENSION RECEIVED
• 16 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 14 Nov 2022 — SOU EXTENSION 4 GRANTED
• 14 Nov 2022 — SOU EXTENSION 4 FILED
• 14 Nov 2022 — SOU TEAS EXTENSION RECEIVED
• 03 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 01 Jun 2022 — SOU EXTENSION 3 GRANTED
• 01 Jun 2022 — SOU EXTENSION 3 FILED
• 01 Jun 2022 — SOU TEAS EXTENSION RECEIVED